|
1
|
Wu KQ, Muratore CS, So EY, Sun C, Dubielecka PM, Reginato AM and Liang OD: M1 macrophage-induced endothelial-to-mesenchymal transition promotes infantile hemangioma regression. Am J Pathol. 187:2102–2111. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Darrow DH, Greene AK, Mancini AJ and Nopper AJ: Section on Dermatology, Section on Otolaryngology-Head & Neck Surgery, and Section on Plastic Surgery: Diagnosis and management of infantile hemangioma: Executive summary. Pediatrics. 136:786–791. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bischoff J: Progenitor cells in infantile hemangioma. J Craniofac Surg. 20 (Suppl 1):S695–S697. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wong A, Hardy KL, Kitajewski AM, Shawber CJ, Kitajewski JK and Wu JK: Propranolol accelerates adipogenesis in hemangioma stem cells and causes apoptosis of hemangioma endothelial cells. Plast Reconstr Surg. 130:1012–1021. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ji Y, Chen S, Li K, Li L, Xu C and Xiang B: Signaling pathways in the development of infantile hemangioma. J Hematol Oncol. 7:132014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shen W, Huang J and Wang Y: Biological significance of NOTCH signaling strength. Front Cell Dev Biol. 9:6522732021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pierscianek D, Wolf S, Keyvani K, El Hindy N, Stein KP, Sandalcioglu IE, Sure U, Mueller O and Zhu Y: Study of angiogenic signaling pathways in hemangioblastoma. Neuropathology. 37:3–11. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Baselga Torres E, Bernabéu Wittel J, van Esso Arbolave DL, Febrer Bosch MI, Carrasco Sanz Á, de Lucas Laguna R, Del Pozo Losada J, Hernández Martín Á, Jiménez Montañés L, López Gutiérrez JC, et al: Spanish consensus on infantile haemangioma. An Pediatr (Barc). 85:256–265. 2016.(In Spanish). View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Calicchio ML, Collins T and Kozakewich HP: Identification of signaling systems in proliferating and involuting phase infantile hemangiomas by genome-wide transcriptional profiling. Am J Pathol. 174:1638–1649. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu JK and Kitajewski JK: A potential role for notch signaling in the pathogenesis and regulation of hemangiomas. J Craniofac Surg. 20 (Suppl 1):S698–S702. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wu J, Adepoju O, De Silva D, Baribault K, Boscolo E, Bischoff J and Kitajewski J: A switch in Notch gene expression parallels stem cell to endothelial transition in infantile hemangioma. Angiogenesis. 13:15–23. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gama-Norton L, Ferrando E, Ruiz-Herguido C, Liu Z, Guiu J, Islam AB, Lee SU, Yan M, Guidos CJ, López-Bigas N, et al: Notch signal strength controls cell fate in the haemogenic endothelium. Nat Comm. 6:85102015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang P, Yan X, Chen Y, Yang Z and Han H: Notch signaling in blood vessels: From morphogenesis to homeostasis. Sci China Life Sci. 57:774–80. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kopan R and Ilagan MX: The canonical Notch signaling pathway: Unfolding the activation mechanism. Cell. 137:216–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Grant ZL and Coultas L: Growth factor signaling pathways in vascular development and disease. Growth Factors. 37:53–67. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mailhos C, Modlich U, Lewis J, Harris A, Bicknell R and Ish-Horowitz D: Delta4, an endothelial specific notch ligand expressed at sites of physiological and tumor angiogenesis. Differentiation. 69:135–144. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Leslie JD, Ariza-McNaughton L, Bermange AL, McAdow R, Johnson SL and Lewis J: Endothelial signaling by the Notch ligand Delta-like 4 restricts angiogenesis. Development. 134:839–844. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Goruganthu MUL, Shanker A, Dikov MM and Carbone DP: Specific targeting of Notch ligand-receptor interactions to modulate immune responses: A review of clinical and preclinical findings. Front Immunol. 11:19582020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang H, Wei T, Johnson A, Sun R, Richter G and Strub GM: NOTCH pathway activation in infantile hemangiomas. J Vasc Surg Venous Lymphat Disord. 9:489–496. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Song BQ, Chi Y, Li X, Du WJ, Han ZB, Tian JJ, Li JJ, Chen F, Wu HH, Han LX, et al: Inhibition of Notch signaling promotes the adipogenic differentiation of mesenchymal stem cells through autophagy activation and PTEN-PI3K/AKT/mTOR pathway. Cell Physiol Biochem. 36:1991–2002. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sandel DA, Liu M, Ogbonnaya N and Newman JJ: Notch3 is involved in adipogenesis of human adipose-derived stromal/stem cells. Biochemie. 150:31–36. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chartoumpekis DV, Palliyaguru DL, Wakabayashi N, Khoo NK, Schoiswohl G, O'Doherty RM and Kensler TW: Notch intracellular domain overexpression in adipocytes confers lipodystrophy in mice. Mol Metab. 4:543–550. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nandagopal N, Santat LA and Elowitz MB: Cis-activation in the Notch signaling pathway. Elife. 8:e378802019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
van Tetering G and Vooijs M: Proteolytic cleavage of Notch: ‘HIT and RUN’. Curr Mol Med. 11:255–269. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sprinzak D and Blacklow SC: Biophysics of Notch signaling. Annu Rev Biophys. 50:157–189. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dong Z, Huo J, Liang A, Chen J, Chen G and Liu D: Gamma-Secretase Inhibitor (DAPT), a potential therapeutic target drug, caused neurotoxicity in planarian regeneration by inhibiting Notch signaling pathway. Sci Total Environ. 781:1467352021. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Menapace D, Mitkov M, Towbin R and Hogeling M: The changing face of complicated infantile hemangioma treatment. Pediatr Radiol. 46:1494–1506. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen ZY, Wang QN, Zhu YH, Zhou LY, Xu T, He ZY and Yang Y: Progress in the treatment of infantile hemangioma. Ann Transl Med. 7:6922019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dai G, Deng S, Guo W, Yu L, Yang J, Zhou S and Gao T: Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma. Mol Carcinog. 58:3–18. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hans CP, Sharma N, Dev R, Blain JM, Tonniges J and Agarwal G: DAPT, a potent Notch inhibitor regresses actively growing abdominal aortic aneurysm via divergent pathways. Clin Sci (Lond). 134:1555–1572. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kangsamaksin T, Murtomaki A, Kofler NM, Cuervo H, Chaudhri RA, Tattersall IW, Rosenstiel PE, Shawber CJ and Kitajewski J: NOTCH decoys that selectively block DLL/NOTCH or JAG/NOTCH disrupt angiogenesis by unique mechanisms to inhibit tumor growth. Cancer Discov. 5:182–197. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kerr G, Sheldon H, Chaikuad A, Alfano I, von Delft F, Bullock AN and Harris AL: A small molecule targeting ALK1 prevents Notch cooperativity and inhibits functional angiogenesis. Angiogenesis. 18:209–217. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Patrad E, Niapour A, Farassati F and Amani M: Combination treatment of all-trans retinoic acid (ATRA) and γ-secretase inhibitor (DAPT) cause growth inhibition and apoptosis induction in the human gastric cancer cell line. Cytotechnology. 70:865–877. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu F, Chu HX, Han JS, Sun X, Chen J, Qiu XL, Zheng XH, Jia B and Zhao JJ: Inhibitory effect of the Notch pathway-inhibitor DAPT on invasion and metastasis of tongue cancer via lncRNA-KAT14 regulation. Eur Rev Med Pharmacol Sci. 24:189–199. 2020.PubMed/NCBI
|
|
35
|
van der Vleuten CJM and Raphael MF: Infantile haemangioma; refer and treat on time. Ned Tijdschr Geneeskd. 163:D37002019.(In Dutch). PubMed/NCBI
|
|
36
|
Wu Y, Li H, Xie J, Wang F, Cao D and Lou Y: MiR-139-5p affects cell proliferation, migration and adipogenesis by targeting insulin-like growth factor 1 receptor in hemangioma stem cells. Int J Mol Med. 45:569–577. 2020.PubMed/NCBI
|
|
37
|
Picard A, Boscolo E, Khan ZA, Bartch TC, Mulliken JB, Vazquez MP and Bischoff J: IGF-2 and FLT-1/VEGF-R1 mRNA levels reveal distinctions and similarities between congenital and common infantile hemangioma. Pediatr Res. 63:263–267. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang K, Wang F, Huang J, Lou Y, Xie J, Li H, Cao D and Huang X: Insulin-like growth factor 2 promotes the adipogenesis of hemangioma-derived stem cells. Exp Ther Med. 17:1663–1669. 2019.PubMed/NCBI
|
|
40
|
Li L, Tang P, Li S, Qin X, Yang H, Wu C and Liu Y: Notch signaling pathway networks in cancer metastasis: A new target for cancer therapy. Med Oncol. 34:1802017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ba K, Yang X, Wu L, Wei X, Fu N, Fu Y, Cai X, Yao Y, Ge Y and Lin Y: Jagged-1-mediated activation of notch signaling induces adipogenesis of adipose-derived stem cells. Cell Prolif. 45:538–544. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Boucher JM, Ryzhova L, Harrington A, Davis-Knowlton J, Turner JE, Cooper E, Maridas D, Ryzhov S, Rosen CJ, Vary CPH and Liaw L: Pathological conversion of mouse perivascular adipose tissue by notch activation. Arterioscler Thromb Vasc Biol. 40:2227–2243. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yin X, Wei H, Wu S, Wang Z, Liu B, Guo L, Bi H and Guo D: DAPT reverses the Th17/Treg imbalance in experimental autoimmune uveitis in vitro via inhibiting Notch signaling pathway. Int Immunopharmacol. 79:1061072020. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Sun W, Li J, Li Y, Zheng J, Zhang X, Huang X and Li S: Gamma-secretase inhibitor, DAPT, prevents the development of retinopathy of prematurity in a rat model by regulating the Delta-Like Ligand 4/Notch Homolog-1 (DLL4/Notch-1) pathway. Med Sci Monit. 25:492–499. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Svedružić ŽM, Popović K and Šendula-Jengić V: Modulators of γ-secretase activity can facilitate the toxic side-effects and pathogenesis of Alzheimer's disease. PLoS One. 8:e507592013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wang M, Ma X, Wang J, Wang L and Wang Y: Pretreatment with the γ-secretase inhibitor DAPT sensitizes drug-resistant ovarian cancer cells to cisplatin by downregulation of Notch signaling. Int J Oncol. 44:1401–1409. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Su F, Zhu S, Ruan J, Muftuoglu Y, Zhang L and Yuan Q: Combination therapy of RY10-4 with the γ-secretase inhibitor DAPT shows promise in treating HER2-amplified breast cancer. Oncotarget. 7:4142–4154. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Mori M, Miyamoto T, Yakushiji H, Ohno S, Miyake Y, Sakaguchi T, Hattori M, Hongo A, Nakaizumi A, Ueda M and Ohno E: Effects of N-[N-(3,5-difluorophenacetyl-L-alanyl)]-S-phenylglycine t-butyl ester (DAPT) on cell proliferation and apoptosis in Ishikawa endometrial cancer cells. Hum Cell. 25:9–15. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Li JY, Li RJ and Wang HD: γ-secretase inhibitor DAPT sensitizes t-AUCB-induced apoptosis of human glioblastoma cells in vitro via blocking the p38 MAPK/MAPKAPK2/Hsp27 pathway. Acta Pharmacol Sin. 35:825–831. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Hubmann R, Sieghart W, Schnabl S, Araghi M, Hilgarth M, Reiter M, Demirtas D, Valent P, Zielinski C, Jäger U and Shehata M: Gliotoxin targets nuclear NOTCH2 in human solid tumor derived cell lines in vitro and inhibits melanoma growth in xenograft mouse model. Front Pharmacol. 8:3192017. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Rodríguez-Cano MM, González-Gómez MJ, Sánchez-Solana B, Monsalve EM, Díaz-Guerra MM, Laborda J, Nueda ML and Baladrón V: NOTCH receptors and DLK proteins enhance brown adipogenesis in mesenchymal C3H10T1/2 cells. Cells. 9:20322020. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Marey HM, Elmazar HF, Mandour SS and Khairy HA: Combined oral and topical beta blockers for the treatment of early proliferative superficial periocular infantile capillary hemangioma. J Pediatr Ophthalmol Strabismus. 55:37–42. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Reshi L, Wang HV, Hui CF, Su YC and Hong JR: Anti-apoptotic genes Bcl-2 and Bcl-xL overexpression can block iridovirus serine/threonine kinase-induced Bax/mitochondria-mediated cell death in GF-1 cells. Fish Shellfish Immunol. 61:120–129. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Reshi L, Wu HC, Wu JL, Wang HV and Hong JR: GSIV serine/threenine kinase can induee apeptetie cell death via p53 and pro-apoptotic gene Bax upregulation in fish cells. Apoptosis. 21:443–458. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Ma SB, Nguyen TN, Tan I, Ninnis R, Iyer S, Stroud DA, Menard M, Kluck RM, Ryan MT and Dewson G: Bax targets mitochondria by distinct mechanisms before or during apoptotic cell death: A requirement for VDAC2 or Bak for efficient Bax apoptotic function. Cell Death Differ. 21:1925–1935. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Wang F, Long J, Li L, Zhao ZB, Wei F, Yao Y, Qiu WJ, Wu ZX, Luo QQ, Liu W, et al: Mutations in the notch signalling pathway are associated with enhanced anti-tumour immunity in colorectal cancer. J Cell Mol Med. 24:12176–12187. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Bridges E, Sheldon H, Kleibeuker E, Ramberger E, Zois C, Barnard A, Harjes U, Li JL, Masiero M, MacLaren R and Harris A: RHOQ is induced by DLL4 and regulates angiogenesis by determining the intracellular route of the Notch intracellular domain. Angiogenesis. 23:493–513. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Xue P, Hou Y, Zuo Z, Wang Z, Ren S, Dong J, Fu J, Wang H, Andersen ME, Zhang Q, et al: Long isoforms of NRF1 negatively regulate adipogenesis via suppression of PPARγ expression. Redox Biol. 30:1014142020. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Musri MM and Párrizas M: Epigenetic regulation of adipogenesis. Curr Opin Clin Nutr Metab Care. 15:342–349. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Lee JE, Schmidt H, Lai B and Ge K: Transcriptional and epigenomic regulation of adipogenesis. Mol Cell Biol. 39:e00601–e00618. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Xu Z, Meng SH, Bai JG, Sun C, Zhao LL, Tang RF, Yin ZL, Yin ZL, Ji JW, Yang W and Ma GJ: C/EBPα Regulates FOXC1 to modulate tumor growth by interacting with PPARγ in hepatocellular carcinoma. Curr Cancer Drug Targets. 20:59–66. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Laviola L, Natalicchio A and Giorgino F: The IGF-I signaling pathway. Curr Pharm Des. 13:663–669. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Weroha SJ and Haluska P: The insulin-like growth factor system in cancer. Endocrinol Metab Clin North Am. 41335–350. (vi)2012. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Zaher H, Rasheed H, El-Komy MM, Hegazy RA, Gawdat HI, Abdel Halim DM, Abdel Hay RM, Hegazy RA and Mohy AM: Propranolol versus captopril in the treatment of infantile hemangioma (IH): A randomized controlled trial. J Am Acad Dermatol. 74:499–505. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Ferreira Mendes JM, de Faro Valverde L, Torres Andion Vidal M, Paredes BD, Coelho P, Allahdadi KJ, Coletta RD, Souza BSF and Rocha CAG: Effects of IGF-1 on proliferation, angiogenesis, tumor stem cell populations and activation of AKT and hedgehog pathways in oral squamous cell carcinoma. Int J Mol Sci. 21:64872020. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Wang F, Li H, Lou Y, Xie J, Cao D and Huang X: Insulinlike growth factor I promotes adipogenesis in hemangioma stem cells from infantile hemangiomas. Mol Med Rep. 19:2825–2830. 2019.PubMed/NCBI
|
|
67
|
Fuentes-Baile M, Ventero MP, Encinar JA, García-Morales P, Poveda-Deltell M, Pérez-Valenciano E, Barberá VM, Gallego-Plazas J, Rodríguez-Lescure Á, Martín-Nieto J and Saceda M: Differential effects of IGF-1R small molecule tyrosine kinase inhibitors BMS-754807 and OSI-906 on human cancer cell lines. Cancers (Basel). 12:37172020. View Article : Google Scholar : PubMed/NCBI
|
